课题基金 / 基金详情

Relations of a New Metabolic Pathway and Immunosuppressive Effects of Urocanic Acid to its Isomerization by Exposure of Skin to Ultraviolet Light

Relations of a New Metabolic Pathway and Immunosuppressive Effects of Urocanic Acid to its Isomerization by Exposure of Skin to Ultraviolet Light
尿刊酸的新代谢途径和免疫抑制作用与其皮肤暴露于紫外线引起的异构化的关系
批准号:
08836008
负责人:
KUNUTA Masahiro
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the skin, only trans-urocanic acid is formed from L-histidine by histidine ammonia-lyase and then accumulated in epidermis because of the absence of urocanate hydratase from the skin. The epidermal urocanic acid isomerized to the cis isomer by ultraviolet light. However, physiological functions of the accumulation and of the isomerization have not been elucidated. This research deals with a new pathway of urocanic acid metabolism, which is initiated by the adduction of glutathione to urocanic acid to form a glutathione S-conjugated imidazole compound (I), and also with its physiological roles. We previously suggested that the metabolism related to the trans-cis isomerization and the elimination of the epidermal urocanic acid under conditions of sunlight irradation. New knowledges and results obtained are as follows : 1, Three additional metabolites of compound I were specified, and the new metabolic pathway has been established completely ; 2, Compound I and its metabolites located in the pathway have an asymmetric beta-carbon atom on the skeletal imidazolepropanoate part of their molecules, i.e., the existance of two diastereomers of each metabolite ; 3, The two diastereomers of each metabolite were prepared, purified by ion-exchangers, and characterizad by physicochemical analyzes ; 4, A new method for simultaneous determination of the diastereomers was developed by capillary electrophoresis, and this method achieved characterization of the enzymatic recognition of stereoisomerism on the beta-carbon atom of their molecules ; 5, A great inhibitory effect of compound I on gamma-glutamyltransferase activity was elucidated and this involves a physiological importance of the formation of compound I under conditions of sunlight irradiation probably to increase intracellular and/or extracellular levels of glutathione, and to protect from oxidative stresses or damages in tissues caused by sunlight.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
Kinuta, M.^*, Shimizu, H.et al.: "Identification of S-〔2-carboxy-1-(1H-imidazol-4-yl)ethyl〕-3-mercaptopyruvic acid with a metabolic intermediate between S-〔2-carboxy-1-(1H-imidazol-4-yl)ethyl〕-L-cysteine and S-〔2-carboxy-1-(1H-imidazol-4-yl)ethyl〕-3-merca
Kinuta, M.^*, Shimizu, H.et al.:“用 S-[2-羧基-1-(1H-咪唑-4-基)乙基]-3-巯基丙酮酸与 S-之间的代谢中间体进行鉴定[2-羧基-1-(1H-咪唑-4-基)乙基]-L-半胱氨酸和S-[2-羧基-1-(1H-咪唑-4-基)乙基]-3-merca
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shimizu, H.and Kinuta, M.^*: "Inhibitory effects in vitro of S-〔2-carboxy-1-(1H-imidazol-4-yl)ethyl〕 glutathione,a proposed metabolite of L-histidine,on γ-glutamyltransferase activity" Biochimica et Biophysica Acta. (in press). (1998)
Shimizu, H. 和 Kinuta, M.^*:“S-〔2-羧基-1-(1H-咪唑-4-基)乙基〕谷胱甘肽(L-组氨酸的拟议代谢物)对 γ 的体外抑制作用-谷氨酰转移酶活性”Biochimica et Biophysicala Acta.(印刷中)。(1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kinuta, M.^*, Shimizu, H.et al.: "Determination of chiral catabolites from S-〔2-carboxy-1-(1H-imidazol-4-yl)ethyl〕 glutathione,a proposed metabolite of L-histidine,by capillary electrophoresis" Journal of Chromatography A. 802 (1). 133-141 (1998)
Kinuta, M.^*, Shimizu, H.et al.:“测定 S-[2-羧基-1-(1H-咪唑-4-基)乙基]谷胱甘肽(一种 L-组氨酸的拟议代谢物)的手性分解代谢物,通过毛细管电泳”《色谱杂志》A. 802 (1). 133-141 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kinuta, M., Shimizu, H.and Ubuka, T.: "Analyzes of S- [2-carboxy-1- (1H-imidazol-4-yl) ethyl] glutathione metabolites by capillary electrrophoresis." Seikagaku. 69 (7) (abstract). 675 (1997)
Kinuta, M.、Shimizu, H. 和 Ubuka, T.:“通过毛细管电泳分析 S-[2-羧基-1-(1H-咪唑-4-基)乙基]谷胱甘肽代谢物。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
29
    海外基金